FierceBiotech ١٧ ديسمبر ٢٠٢٥ Medtronic rolls out new peripheral thrombectomy system while making advances in brain bleeds
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’
FierceBiotech ١٦ ديسمبر ٢٠٢٥ December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B
FierceBiotech ١٦ ديسمبر ٢٠٢٥ Xoma acquires another struggling biotech, this time zeroing in on Generation Bio
FierceBiotech ١٦ ديسمبر ٢٠٢٥ Aldeyra dry eye disease candidate hit by FDA delay amid shifting agency guidance, biotech says
FierceBiotech ١٦ ديسمبر ٢٠٢٥ Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug
FierceBiotech ١٦ ديسمبر ٢٠٢٥ MapLight brightens SandboxAQ with new deal to discover new CNS candidates
FierceBiotech ١٦ ديسمبر ٢٠٢٥ Sanofi signs $1B biobucks pact for Alzheimer’s asset in 2nd biotech deal of the day
FierceBiotech ١٥ ديسمبر ٢٠٢٥ Pfizer, Sanofi pull out checkbooks for separate year-end autoimmune pacts
FierceBiotech ١٥ ديسمبر ٢٠٢٥ J&J-backed Link launches with $60M, plan to create next-gen CAR-T therapies
FierceBiotech ١٥ ديسمبر ٢٠٢٥ Aviceda geographic atrophy hopeful fails to top Astellas' med in phase 2
FierceBiotech ١٥ ديسمبر ٢٠٢٥ Kyverna gains clear view to first CAR-T approval for autoimmune disease after 'truly remarkable' SPS readout